IRES-based Vector Coexpressing FGF2 and Cyr61 Provides Synergistic and Safe Therapeutics of Lower Limb Ischemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IRES-based Vector Coexpressing FGF2 and Cyr61 Provides Synergistic and Safe Therapeutics of Lower Limb Ischemia

Published:2009-12 Issue:12 Volume:17 Page:2010-2019
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Rayssac Audrey,Neveu Charles,Pucelle Mélanie,Van den Berghe Loïc,Prado-Lourenco Leonel,Arnal Jean-François,Chaufour Xavier,Prats Anne-Catherine

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference24 articles.

1. Obesity, risk factors, and predicting cardiovascular events;Criqui;Circulation,2005

2. Therapeutic angiogenesis in cardiovascular disease;Al Sabti;J Cardiothorac Surg,2007

3. Gene transfer as a tool to induce therapeutic vascular growth;Ylä-Herttuala;Nat Med,2003

4. Gene therapy of the ischemic lower limb–Therapeutic angiogenesis;Bobek;Vascul Pharmacol,2006

5. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb;Isner;Lancet,1996

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SIRT3 and SIRT4 double-genes remodeled the mitochondrial network to induce hepatocellular carcinoma cell line differentiation and suppress malignant phenotypes;Biochemical Pharmacology;2024-05

2. Internal Ribosome Entry Site (IRES)-Mediated Translation and Its Potential for Novel mRNA-Based Therapy Development;Biomedicines;2022-08-02

3. CYR61 improves muscle force recreation in a rabbit trauma model;Technology and Health Care;2021-11-01

4. Production and Application of Multicistronic Constructs for Various Human Disease Therapies;Pharmaceutics;2019-11-06

5. Identification of Cysteine‐Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in Scleroderma;Arthritis & Rheumatology;2019-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3